Taiwan FDA registration 80614f0061c91c5287dd7d478006f220

Primmus CLC385 Automatic High Pressure Liquid Chromatography Instrument

TW: 普林莫斯CLC385全自動高壓液相層析儀

Taiwan·Risk Class 1·Trinity Biotech (Primus Corporation dba Trinity Biotech)·Registered Jan 23, 2006 – Jan 23, 2016Cancelled

Registration details

Analysis ID: 80614f0061c91c5287dd7d478006f220
Customs Code: DHA04400255101

Company information

Manufacturer: Trinity Biotech (Primus Corporation dba Trinity Biotech)
Manufacturer Country: United States
Authorized Representative: PROGRESSIVE GROUP INC.

Product details

Intended Use: An analyzer for the automatic quantitative detection of glycosylated hemoglobin and mutated hemoglobin by high-pressure liquid chromatography.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.2260 High-pressure liquid chromatography for clinical use
Import Information: import

Dates and status

Registration Date: Jan 23, 2006
Expiry Date: Jan 23, 2016
Cancellation Date: May 28, 2018

Cancellation information

Status: Logged out
Reason: 許可證已逾有效期

About this record

Access comprehensive regulatory information for Primmus CLC385 Automatic High Pressure Liquid Chromatography Instrument in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 80614f0061c91c5287dd7d478006f220 and manufactured by Trinity Biotech (Primus Corporation dba Trinity Biotech). The authorized representative in Taiwan is PROGRESSIVE GROUP INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.